Pfizer Asks For Quick Review In Norvasc Feud

Law360, New York (June 4, 2007, 12:00 AM EDT) -- Pfizer Inc. has asked the nation's highest court to expedite its bid for a writ of certiorari in its patent feud with Apotex Inc. over blockbuster blood pressure drug Norvasc, arguing that a lower court's recent refusal to rehear the case could have “potentially wide-reaching consequences for the entire pharmaceutical research industry.”

Pfizer on May 30 filed with the U.S. Supreme Court a motion to expedite consideration of its petition for a writ of certiorari, which was submitted to the court on the same day....
To view the full article, register now.